Laboratory Information:
National Heart, Lung, and Blood Institute
6705 Rockledge Dr.
Suite 6018 (MSC 7992)
Bethesda, MD 20892
Website: http://www.nhlbi.nih.gov/
Technology Transfer Website: http://www.nhlbi.nih.gov/resources/tt/index.htm
Agency/Department: Dept. of Health and Human Services
Region: Mid-Atlantic
FLC Laboratory Representative:
Dr. Alan Deutch
Phone: (301) 402-5579
Fax: 301-594-3080
Email: deutcha@nhlbi.nih.gov
Background/History of the Laboratory:
The National
Heart, Lung, and Blood Institute (NHLBI) provides leadership
for a national program in diseases of the heart, blood
vessels, lung, and blood; blood resources; and sleep
disorders. Since October 1997, the NHLBI has also had
administrative responsibility for the NIH Woman's Health
Initiative. The Institute plans, conducts, fosters, and
supports an integrated and coordinated program of basic
research, clinical investigations and trials, observational
studies, and demonstration and education projects. Research
is related to the causes, prevention, diagnosis, and
treatment of heart, blood vessel, lung, and blood diseases;
and sleep disorders. The NHLBI plans and directs research in
development and evaluation of interventions and devices
related to prevention, treatment, and rehabilitation of
patients suffering from such diseases and disorders. It also
supports research on clinical use of blood and all aspects of
the management of blood resources. Research is conducted in
the Institute's own laboratories and by scientific
institutions and individuals supported by research grants and
contracts. For health professionals and the public, the NHLBI
conducts educational activities, including development and
dissemination of materials in the above areas, with an
emphasis on prevention. The NHLBI supports research training
and career development of new and established researchers in
fundamental sciences and clinical disciplines to enable them
to conduct basic and clinical research related to heart,
blood vessel, lung, and blood diseases; sleep disorders; and
blood resources through individual and institutional research
training awards and career development awards. The Institute
coordinates relevant activities in the above areas, including
the related causes of stroke, with other research institutes
and federal health programs. Relationships are maintained
with institutions and professional associations, and with
international, national, state, and local officials as well
as voluntary agencies and organizations working in the above
areas.
Facilities:
Technology Transfer Mechanisms:
- Clinical Trial Agreements (CTAs)
- Confidential Disclosure Agreements (CDAs)
- Cooperative Research and Development Agreements (CRADAs)
- Facility Sharing
- Material Transfer Agreements
- Patents and Licensing
- Small Business Innovative Research (SBIR)
- Technical Assistance
Technology Areas of Expertise:
- Sleep Disorders
- Sudden Cardiac Arrest
- Tetralogy of Fallot
- Thalassemia
- Varicose Veins
- Vasculitis
- Ventricular Septal Defect
- Von Willebrand Disease
- Heart and Blood Vessel Diseases
- Heart Attack
- Heart Failure
- Heart Murmur
- Hemochromatosis
- Hemolytic Anemia
- Hemophilia
- High Blood Cholesterol
- High Blood Pressure
- Hypotension
- Idiopathic Thrombocytopenic Purpura
- Congenital Heart Defects
- COPD
- Coronary Artery Disease
- Cystic Fibrosis
- Deep Vein Thrombosis
- Patent Ductus Arteriosus
- Peripheral Arterial Disease
- Pernicious Anemia
- Polycythemia Vera
- Pulmonary Arterial Hypertension
- Pulmonary Embolism
- Raynaud's Disease
- Sarcoidosis
- Sickle Cell Anemia
